NLS Pharmaceutics (NASDAQ:NCEL) Stock Jumps 3.5% – What’s Next?

NLS Pharmaceutics Ltd. (NASDAQ:NCEL) shares were up 3.5% during mid-day trading on Tuesday. The stock traded as high as $3.20 and last traded at $2.96. 7,212 shares traded hands during trading, an increase of 35% from the average session volume of 5,342 shares. The stock had previously closed at $2.86.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Laidlaw assumed coverage on NLS Pharmaceutics in a research note on Monday, July 13th. They issued a “buy” rating and a $23.00 price objective on the stock. Weiss Ratings raised NLS Pharmaceutics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, September 18th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, NLS Pharmaceutics presently has an average rating of “Hold” and a consensus price target of $23.00.

NLS Pharmaceutics Trading Up 2.3%

The stock’s fifty day simple moving average is $3.24 and its 200-day simple moving average is $3.26.

NLS Pharmaceutics (NASDAQ:NCEL) last posted its quarterly earnings data on Friday, September 18th. The company reported ($0.48) earnings per share for the quarter.

About NLS Pharmaceutics

NLS Pharmaceutics Ltd. (NASDAQ: NCEL) is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders, particularly conditions involving excessive daytime sleepiness and impaired wakefulness.

The company’s lead development program is Quilience, an extended-release formulation of mazindol being investigated for sleep-wake disorders, including narcolepsy and idiopathic hypersomnia. NLS Pharmaceutics has also pursued additional mazindol-based therapies and other potential treatments for neurological and psychiatric conditions.

NLS Pharmaceutics is headquartered in Switzerland and conducts its research and clinical development activities through collaborations and programs intended for international markets.